The U.S. Food and Drug Administration (FDA) has issued a call to action for nicotine pouch manufacturers: adopt child-resistant packaging to help prevent accidental exposure, particularly among young children. The agency’s announcement follows a rise in reported incidents of ingestion and highlights how packaging plays a central role in both consumer safety and regulatory compliance. 

What the FDA Is Asking of Manufacturers 

In its statement, the FDA urged all manufacturers to take proactive steps, including: 

• Adopting child-resistant packaging across all nicotine pouch products 
• Working with their assigned Regulatory Health Project Manager if they plan to update packaging for products with pending Premarket Tobacco Applications (PMTAs) 
• Ensuring product design, labeling, and storage practices reduce the risk of unintended exposure 

Notably, all 20 nicotine pouch products already authorized by the FDA are sold in child-resistant containers—setting a clear benchmark for industry best practices. 

 

What This Means for Manufacturers with PMTA Applications 

For nicotine pouch companies, this announcement is more than just safety guidance—it also signals how FDA is approaching product review. Under the PMTA process, the agency evaluates packaging, labeling, and marketing in addition to the product itself. 

Key takeaways for manufacturers include: 

Child-resistant packaging is the standard. Every FDA-authorized pouch already incorporates it, showing how closely it is tied to authorization. 

Pending PMTAs can be strengthened. Companies with applications under review may update FDA about packaging improvements, demonstrating responsiveness to safety concerns. 

Future applications should plan ahead. Incorporating child-resistant features from the start helps align with FDA expectations and may support a smoother path to authorization. 

Market access depends on compliance. As states increasingly adopt registry laws that require FDA authorization for sales, aligning packaging with federal guidance helps ensure products remain eligible across multiple markets. 

For manufacturers, this should be seen less as an additional barrier and more as an opportunity to showcase commitment to consumer safety and regulatory readiness. 

 

Looking Ahead 

Nicotine pouches are a rapidly growing category in the U.S. marketplace. The FDA’s call for child-resistant packaging reflects both the product’s popularity and the responsibility that comes with it. By adopting stronger safety measures now, manufacturers can protect children, build consumer trust, and strengthen their position in an evolving regulatory environment. 

For consumers, the message is equally clear: nicotine pouches are for adults only, and proper storage and handling remain essential.